The GMP Insider

An out-of-specification result lands on your desk — and one wrong decision in the next hour can manufacture the evidence for your own warning letter. Marcus and Priya break down the two-phase OOS investigation step by step: Phase 1, the laboratory investigation, and Phase 2, the full-scale investigation, under 21 CFR 211.192 — from the Barr Labs decision to the retest rules to what to do on Monday...

When an FDA investigator stops trusting your data, the inspection is over — because if the records can't be trusted, nothing built on them can be. Marcus and Priya break down all nine ALCOA+ principles — Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available — what investigators actually find when each one is missing, and the Monday-morning fixes that...

Every year, FDA investigators write thousands of 483 observations — and almost every one was avoidable. Marcus and Priya count down the ten most-cited observations in drug manufacturing for 2026, what investigators are actually finding, and exactly how to keep your site off the list. • The #1 most-cited observation — and why it explains the other nine • Data integrity: the fastest-growing citation...

Every shortcut, deferred CAPA, and "we'll fix it later" is a loan — and quality debt charges interest. Repeat deviations, findings, and warning letters are just the payments coming due. • What quality debt is and how it silently accumulates • The interest payments: repeat deviations and FDA findings • Paying it down without stopping the line • Preventing new debt while clearing the old New episode...

Recalls make the headlines. But the real cost of poor quality never makes the press release — it hides in rework, investigations, remediation, and the launches that never happen. • The costs nobody puts on the recall announcement • Rework, investigations, and remediation: the real math • How poor quality taxes every future product launch • Making the business case for quality investment New episod...

A CAPA can address a deviation. But can a CAPA change the conditions that allowed the deviation to happen? In this episode of The GMP Insider , we explore why organizations sometimes continue opening CAPAs for recurring problems without addressing deeper organizational factors. We examine five areas that can determine whether corrective action creates lasting improvement: Leadership behavior — Wha...

A Quality System can pass an audit and still have weaknesses hiding underneath. That's because compliance, effectiveness, and sustainability are not the same thing. In this episode of The GMP Insider , we examine what it really means for a pharmaceutical Quality System to be healthy. Compliance asks: Are we meeting the requirements? Effectiveness asks: Are our controls actually working? Sustainabi...

What if your Quality dashboard is telling you everything is fine—but your Quality System is telling a different story? In pharmaceutical Quality, metrics are essential. But metrics can also create a false sense of confidence when organizations focus on what is easy to measure rather than what truly reflects Quality System health. In this episode of The GMP Insider , we explore the hidden risks beh...

In pharmaceutical Quality, some decisions are difficult not because the science is unclear, but because the consequences of the decision are significant. A batch may be under production pressure. A manufacturing schedule may be at risk. Leadership may be asking for a decision. The available data may not provide complete certainty. And Quality still has to decide. This episode of The GMP Insider ex...

AI governance in the pharmaceutical industry cannot begin after deployment. By that point, critical decisions about data, accountability, human oversight, transparency, risk, and system behavior have already been embedded into the technology. So the better question is: What if ethics were designed into AI from the beginning? In this episode of The GMP Insider , we explore the concept of Ethics by...

What is it really like to work in Quality Assurance at a large pharmaceutical company compared with a smaller organization? The answer goes far beyond company size. In this episode of The GMP Insider , we explore how Big Pharma and Small Pharma can develop very different professional skills, experiences, and perspectives—and why Quality Culture often matters more than organizational scale . Big Ph...

What if the deepest meaning of Pharmaceutical Quality isn't compliance? What if it's caring? Every SOP written, every deviation investigated, every batch reviewed, and every quality decision made represents something bigger than a regulatory requirement. It represents a person who cared enough to do the work right. In this episode of The GMP Insider , we explore the human side of pharmaceutical qu...

Some of the hardest decisions in Pharmaceutical Quality are not difficult because the answer is unclear. They're difficult because the right answer isn't necessarily the popular one. A Quality Leader may have to say no. They may have to escalate an uncomfortable issue. They may have to challenge production pressure. They may have to make a decision that creates short-term frustration but protects...

The most dangerous day in Pharmaceutical Quality isn't necessarily the day an inspector arrives. It may be the day people stop asking questions. A Quality System can appear completely compliant while a much deeper problem develops beneath the surface. SOPs are followed. CAPAs are closed. Metrics are green. Dashboards look perfect. But if people have stopped challenging assumptions, identifying ris...

In Quality Assurance, we often measure success through activity. How many CAPAs were closed? How many deviations were completed? How many investigations were approved? Those metrics are important. But they don't tell the complete story of leadership. In this episode of The GMP Insider , we explore a critical transition in every Quality Assurance career: the shift from being valued for execution to...

Technical knowledge is essential in Pharmaceutical Quality Assurance—but it isn't what separates good professionals from exceptional ones. Curiosity does. In this episode of The GMP Insider , we explore why curiosity is one of the most valuable skills a QA professional can develop and how asking better questions leads to stronger investigations, more effective CAPAs, better risk management, and co...

The most effective Quality Leaders are not remembered for the number of audits they passed or the investigations they closed. They are remembered for the culture they created. In this episode of The GMP Insider , we explore the principle of Quality by Character and why leadership rooted in integrity, humility, trust, and respect builds organizations where quality thrives. Discussion topics include...

In the pharmaceutical industry, inspections, audits, and regulatory compliance are essential. But they are not the ultimate purpose of quality. The true purpose of every Quality Management System is to protect patients by ensuring that every medicine is safe, effective, reliable, and consistently manufactured. In this episode of The GMP Insider , we explore the principle of Quality by Service and...

Pharmaceutical Quality Assurance is often associated with procedures, investigations, documentation, and regulatory compliance. While these responsibilities are essential, they are not the reason most professionals entered the industry. In this episode of The GMP Insider , we explore the principle of Quality by Purpose and why reconnecting with the mission behind our work creates stronger leaders,...

Pharmaceutical quality is built behind the scenes. Patients rarely see the people, processes, investigations, or systems that ensure the medicines they receive are safe, effective, and reliable. Yet every prescription filled and every dose taken reflects an extraordinary act of trust. In this episode of The GMP Insider , we explore the principle of Quality by Trust and why trust is one of the most...

Every pharmaceutical quality system experiences deviations. The difference between average organizations and exceptional ones is not the number of deviations they encounter—it is how they respond to them. In this episode of The GMP Insider , we explore the principle of Quality by Humility and why the willingness to learn from mistakes is one of the most valuable leadership qualities in Pharmaceuti...

One of the most common misconceptions in the pharmaceutical industry is that Quality Assurance alone owns quality. In reality, QA governs the Quality Management System—but quality is created by every individual who designs, manufactures, tests, reviews, and releases a product. In this episode of The GMP Insider , we explore the principle of Quality by Ownership and why shared accountability is the...

In Pharmaceutical Quality Assurance, compliance establishes expectations—but integrity determines how those expectations are fulfilled. Integrity is demonstrated not during inspections, but in the countless everyday decisions made when no one is watching. In this episode of The GMP Insider , we explore why integrity is the cornerstone of trustworthy quality systems and effective quality leadership...

Curiosity is often associated with learning, but in Pharmaceutical Quality Assurance it is also one of the most powerful tools for preventing recurring issues and strengthening quality systems. In this episode of The GMP Insider , we explore why curiosity is a defining characteristic of exceptional Quality professionals and how asking better questions leads to stronger investigations, more effecti...

In Pharmaceutical Quality Assurance, technical knowledge is essential—but it is not enough. Protecting patients also requires the courage to raise concerns, challenge assumptions, and speak up when quality is at risk. In this episode of The GMP Insider , we explore why courage is one of the most important qualities of effective quality leaders and how it shapes a culture of trust, accountability,...